CABIO Biotech (Wuhan) Co., Ltd. ("CABIO" for short), established in September 2004, is a high-tech enterprise underpinned by biotechnology and the first company listed on the Science and Technology Innovation Board (stock code: 688089) in Hubei Province.   

After nearly two decades of development, CABIO has built a complete technology transfer platform of industry chain, incorporating directive breeding of microbial strain, fine regulation of cell, high-efficient separation & purification, preparation, directional transmission, high-throughput detection & analysis, among other technology modules. We provide quality functional ingredients and creative solutions to developers of nutrition and health foods worldwide. We have achieved the industrialization of arachidonic acid (ARA), docosahexenoic acid (DHA), β-carotene (BC), N-acetylneuraminic acid and other products. Our products are widely applied in human nutrition, animal nutrition, personal care and other fields.